Retrieve available abstracts of 26 articles: HTML format
Single Articles
January 2026
RASMUSSEN PV, Strange JE, Nielsen SK, Hansen RB, et al Beta-blocker side-effects in clinical practice: A nationwide approach.
Am Heart J. 2026;291:111-120. PubMedAbstract available
July 2025
MAKUVIRE TT, Latif Z, Atwater S, Shah MK, et al Health Care Access and Risk Factor Control in US adults with Cardiovascular
Disease from 2015 to 2023.
Am Heart J. 2025 Jul 2:S0002-8703(25)00208-X. doi: 10.1016/j.ahj.2025. PubMedAbstract available
May 2025
TANG Y, Jiang C, Guo J, Li Y, et al Study protocol for the healthy family program on population blood pressure: A
multicenter, parallel group, cluster randomized, controlled trial in rural China.
Am Heart J. 2025;283:70-80. PubMedAbstract available
April 2025
LIYANAGE-DON N, Phillips E, Schwartz JE, Chang MJ, et al Implementing Remote Patient Monitoring to Improve Hypertension Control in a
Primary Care Network: Rationale and Design of the Monitor-BP Cluster Randomized
Trial.
Am Heart J. 2025 Apr 8:S0002-8703(25)00122-X. doi: 10.1016/j.ahj.2025. PubMedAbstract available
ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al Novel automated electronic medical record-based VEST (virtual echocardiography
screening tool) algorithm for pulmonary arterial hypertension.
Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025. PubMedAbstract available
February 2025
TIAN Y, Wang X, Hu Z, Yu X, et al Design, rationale, and characterization of the Mobile health based OccuPational
cardiovascular risk intErventioN study (mHealth-OPEN Study).
Am Heart J. 2025 Feb 13:S0002-8703(25)00035-3. doi: 10.1016/j.ahj.2025. PubMedAbstract available
December 2024
SANTORO F, Stiermaier T, Nunez Gil IJ, El-Battrawy I, et al Renin angiotensin system inhibitors and outcome in patients with takotsubo
syndrome: A propensity score analysis of the GEIST registry.
Am Heart J. 2024;278:127-138. PubMedAbstract available
November 2024
SALAM A, Sani MU, Ogah OS, Huffman MD, et al deliVERy of optimal blood pressure coNtrol in afrICA (VERONICA)-Nigeria study:
Rationale and design of a randomized clinical trial.
Am Heart J. 2024;277:66-75. PubMedAbstract available
September 2024
VOLPP KG, Mahraj K, Norton LA, Asch DA, et al Design and Rationale of Penn Medicine Healthy Heart, a Randomized Trial of
Effectiveness of a Centrally Organized Approach to Blood Pressure and Cholesterol
Improvement Among Patients at Elevated Risk of Atherosclerotic Cardiovascular
Disease.
Am Heart J. 2024 Sep 26:S0002-8703(24)00262-X. doi: 10.1016/j.ahj.2024. PubMedAbstract available
KERCHEVAL JB, Narcisse DI, Nguyen M, Rao SV, et al Characterization of peripheral artery disease and associations with traditional
risk factors, mobility, and biomarkers in the project baseline health study.
Am Heart J. 2024;275:183-190. PubMedAbstract available
August 2024
KIM CW, Haji M, Lopes VV, Halladay C, et al Variations in antihypertensive medication treatment and blood pressure control
among Veterans with HIV and existing hypertension.
Am Heart J. 2024 Aug 29:S0002-8703(24)00204-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
SANNA GD, Erre GL, Cameli M, Guerra F, et al Association of sex with in-hospital management and outcomes of patients with
heart failure: data from the REAL-HF registry: The impact of sex in patients
hospitalized for heart failure.
Am Heart J. 2024 Aug 27:S0002-8703(24)00221-7. doi: 10.1016/j.ahj.2024. PubMedAbstract available
JIANG C, Wang Z, Du X, Wang Y, et al Protocol for a randomized controlled trial of intensive blood pressure control on
cardiovascular risk reduction in patients with atrial fibrillation: rationale and
design of the CRAFT trial.
Am Heart J. 2024 Aug 23:S0002-8703(24)00203-5. doi: 10.1016/j.ahj.2024. PubMedAbstract available
CHEN MT, Vollmer BL, Blyler CA, Cameron NA, et al Antihypertensive Medication Prescription Dispensation Among Pregnant Women in the
United States: A Cohort Study.
Am Heart J. 2024 Aug 21:S0002-8703(24)00205-9. doi: 10.1016/j.ahj.2024. PubMedAbstract available
July 2024
POLSINELLI VB, Koczo A, Johnson AE, Elkayam U, et al Race, Hypertensive Disorders of Pregnancy and Outcomes in Peripartum
Cardiomyopathy.
Am Heart J. 2024 Jul 10:S0002-8703(24)00168-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
June 2024
METLOCK FE, Kwapong YA, Evans C, Ouyang P, et al Design and Rationale of the Social Determinants of the Risk of Hypertension in
Women of Reproductive Age (SAFE HEART) Study: An American Heart Association
Research Goes Red Initiative.
Am Heart J. 2024 Jun 9:S0002-8703(24)00138-8. doi: 10.1016/j.ahj.2024. PubMedAbstract available
May 2024
COMMODORE-MENSAH Y, Chen Y, Ogungbe O, Liu X, et al Design and Rationale of the Cardiometabolic Health Program Linked with Community
Health Workers and Mobile Health Telemonitoring to Reduce Health DisparitieS
(LINKED-HEARTS) Program.
Am Heart J. 2024 May 15:S0002-8703(24)00123-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
April 2024
DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al Early Postpartum Blood Pressure Screening is Associated with Increased Detection
of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024. PubMedAbstract available
ZHANG H, Huo X, Ren L, Lu J, et al Design and rationale of the Comprehensive intelligent Hypertension managEment
SyStem (CHESS) evaluation study: a cluster randomized controlled trial for
hypertension management in primary care.
Am Heart J. 2024 Apr 2:S0002-8703(24)00079-6. doi: 10.1016/j.ahj.2024. PubMedAbstract available
March 2024
MILLER HE, Tierney S, Stefanick ML, Mayo JA, et al Vascular health years after a hypertensive disorder of pregnancy: The EPOCH
Study.
Am Heart J. 2024 Mar 12:S0002-8703(24)00055-3. doi: 10.1016/j.ahj.2024. PubMedAbstract available
HAMO CE, Schlamp F, Drenkova K, Jindal M, et al Burden of cardiometabolic risk factors and vascular health.
Am Heart J. 2024;269:201-204. PubMedAbstract available
February 2024
MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI
Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging
Studies.
Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024. PubMedAbstract available
December 2023
CHITTURI KR, Haberman D, Wermers JP, Waksman R, et al Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the
Symplicity Spyral Renal Denervation System.
Am Heart J. 2023 Dec 19:S0002-8703(23)00350-2. doi: 10.1016/j.ahj.2023. PubMedAbstract available
November 2023
KIM M, Choi JH, Kim HK, Kim HL, et al Effects of Intensive Blood Pressure Control on Left Ventricular Hypertrophy in
Aortic Valve Disease.
Am Heart J. 2023 Nov 23:S0002-8703(23)00321-6. doi: 10.1016/j.ahj.2023. PubMedAbstract available
HAFF N, Sreedhara SK, Wood W, Yom-Tov E, et al Testing interventions to reduce clinical inertia in the treatment of
hypertension: rationale and design of a pragmatic randomized controlled trial.
Am Heart J. 2023 Nov 13:S0002-8703(23)00313-7. doi: 10.1016/j.ahj.2023. PubMedAbstract available
GNANENTHIRAN SR, Tan I, Atkins ER, Avolio A, et al Transforming blood pressure control in primary care through a novel remote
decision support strategy based on wearable blood pressure monitoring: The
NEXTGEN-BP randomized trial protocol.
Am Heart J. 2023;265:50-58. PubMedAbstract available